Foundation Medicine announced the expansion of its suite of molecular information-based products with GeneKitTM.
GeneKitTM is a genomics solutions portal for pathologists that is uniquely differentiated by the power of FoundationCORETM.
GeneKit is a cloud-based software solution that complements Interactive Cancer Explorer (ICE 2) with PatientMatchTM, which is the company's innovative physician-facing decision support portal.
GeneKit facilitates the interpretation of genomic data generated by pathologists from targeted next generation sequencing (NGS) and "hot spot" assays.
This integration allows pathologists to more effectively support clinical diagnosis and treatment strategies through the rapid interpretation and efficient reporting of genomic information to oncology care teams.
"To ensure that molecular information is used to inform therapeutic decisions and improve patient care, we are offering pathologists a sophisticated clinical interpretation system. GeneKit will allow pathologists to assess a patient's specific tumor alterations against a knowledgebase of curated genomic variants, relevant scientific research, targeted therapy and clinical trial information, enabling the creation of actionable reports in a timely fashion for care teams," said David J. Daly, chief commercial officer of Foundation Medicine.
"Today, a large number of institutions use manual interpretation procedures that can be incredibly arduous, technical and time-consuming. GeneKit overcomes these challenges of manual reporting and furnishes pathologists with highly relevant clinical and scientific data for the betterment of patient care," said David J. Daly.